We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+37.16%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$24.7M
(+16%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-11.74%
Top 10 Holdings %
Top 10 Hldgs %
60.99%
Holding
128
New
6
Increased
17
Reduced
11
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$7.51M |
| 2 |
KW
Kennedy-Wilson Holdings
KW
|
+$3.02M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
+$1.72M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$1.46M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$1.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$8.13M |
| 2 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$3.9M |
| 3 |
Apollo Global Management
APO
|
+$3.18M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.1M |
| 5 |
FNM.PRT
FEDERAL NATL MTG ASS 08250
FNM.PRT
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.06% |
| 2 | Financials | 16.44% |
| 3 | Industrials | 13.2% |
| 4 | Technology | 8.55% |
| 5 | Communication Services | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$5.59B
| $30.5M | 16.67% |
437,685
-128,240
| -23% | -$8.13M |
|
|
SRCL
2
DELISTED
Stericycle Inc
SRCL
| $15.1M | 8.22% |
269,083
| – | – |
|
|
3
Apollo Global Management
APO
$79.7B
| $15M | 8.18% |
300,000
-72,500
| -19% | -$3.18M |
|
4
Upland Software
UPLD
$13.9M
| $14.1M | 7.71% |
40,650
-650
| -2% | -$203K |
|
|
5
FTAI Aviation
FTAI
$20B
| $9.09M | 4.96% |
+819,700
| New | +$7.51M |
|
|
6
Alphabet (Google) Class C
GOOG
$4.19T
| $7.92M | 4.32% |
112,000
-46,000
| -29% | -$3.1M |
|
7
KKR & Co
KKR
$97.6B
| $5.56M | 3.03% |
180,000
-25,000
| -12% | -$672K |
|
8
FS KKR Capital
FSK
$3.39B
| $5.53M | 3.02% |
395,175
| – | – |
|
9
Calumet Specialty Products
CLMT
$4.2B
| $4.61M | 2.51% |
2,020,000
| – | – |
|
|
CCXI
10
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.32M | 2.36% |
75,033
-25,398
| -25% | -$1.38M |
|
11
Pfizer
PFE
$159B
| $4.31M | 2.35% |
139,023
| – | – |
|
12
LKQ Corp
LKQ
$6.46B
| $3.93M | 2.15% |
150,000
| – | – |
|
13
AbbVie
ABBV
$451B
| $3.71M | 2.02% |
37,769
+2,536
| +7% | +$223K |
|
|
KW
14
DELISTED
Kennedy-Wilson Holdings
KW
| $3.2M | 1.74% |
+210,000
| New | +$3.02M |
|
|
ZGNX
15
DELISTED
Zogenix, Inc.
ZGNX
| $2.85M | 1.56% |
105,607
+52,842
| +100% | +$1.46M |
|
16
Bristol-Myers Squibb
BMY
$136B
| $2.73M | 1.49% |
46,409
+500
| +1% | +$29.9K |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.53M | 1.38% |
8,792
| – | – |
|
|
BLU
18
DELISTED
BELLUS Health Inc.
BLU
| $2.47M | 1.35% |
238,611
-4,000
| -2% | -$40.5K |
|
|
KDMN
19
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.24M | 1.22% |
437,600
+55,700
| +15% | +$250K |
|
|
BDSI
20
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.2M | 1.2% |
505,530
| – | – |
|
21
JPMorgan Chase
JPM
$951B
| $2.17M | 1.18% |
23,050
| – | – |
|
|
TRIL
22
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.14M | 1.17% |
264,225
+127,725
| +94% | +$790K |
|
23
Xenon Pharmaceuticals
XENE
$5.81B
| $2.12M | 1.16% |
169,000
-6,204
| -4% | -$79K |
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.03M | 1.11% |
36,531
-23,000
| -39% | -$984K |
|
|
25
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.89M | 1.03% |
397,361
+337,371
| +562% | +$1.35M |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q2 2020 Portfolio in Review
As of Q2 2020, David M. Knott held 128 positions worth $183M, up 16% from $158M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
David M. Knott withdrew a net $21.5M in Q2 2020, closing 35 positions and reducing 11 holdings. Its most notable exit was FEDERAL NATL MTG ASS 08250, an estimated $2.19M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Financials and Industrials.
Against the trend, David M. Knott opened a new position in FTAI Aviation worth $9.09M.
- David M. Knott's largest Q2 2020 buy was FTAI Aviation: 819,700 shares worth $9.09M.
- David M. Knott added most to Aurinia Pharmaceuticals in Q2 2020, an estimated $1.72M increase.
- David M. Knott's biggest Q2 2020 reduction was Ligand Pharmaceuticals, cutting an estimated $8.13M.
- David M. Knott fully exited FEDERAL NATL MTG ASS 08250 in Q2 2020, selling an estimated $2.19M.
- David M. Knott's ten largest holdings make up 61% of its $183M portfolio in Q2 2020.
- David M. Knott opened 6 new positions and closed 35 in Q2 2020.
- David M. Knott's portfolio value rose 16% quarter-over-quarter to $183M.
Based on David M. Knott's 13F filing for Q2 2020, filed 12 Aug 2020.